Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 5 studies | 54% ± 27% | |
adipocyte | 4 studies | 25% ± 2% | |
fibroblast | 3 studies | 53% ± 17% |
Insufficient scRNA-seq data for expression of ENPP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2753.34 | 459 / 459 | 95% | 37.66 | 1064 / 1118 |
liver | 100% | 5136.95 | 226 / 226 | 93% | 16.78 | 378 / 406 |
thymus | 100% | 4736.67 | 653 / 653 | 90% | 22.69 | 542 / 605 |
prostate | 98% | 1383.76 | 240 / 245 | 90% | 6.32 | 453 / 502 |
pancreas | 100% | 2344.64 | 328 / 328 | 74% | 5.49 | 132 / 178 |
adrenal gland | 88% | 767.70 | 228 / 258 | 58% | 4.45 | 133 / 230 |
kidney | 97% | 1069.16 | 86 / 89 | 49% | 4.77 | 443 / 901 |
ovary | 100% | 2953.48 | 180 / 180 | 38% | 2.65 | 162 / 430 |
skin | 71% | 707.67 | 1277 / 1809 | 67% | 7.72 | 314 / 472 |
stomach | 77% | 482.34 | 278 / 359 | 56% | 3.80 | 161 / 286 |
uterus | 99% | 6858.00 | 169 / 170 | 29% | 4.91 | 131 / 459 |
esophagus | 69% | 653.69 | 1003 / 1445 | 48% | 2.84 | 87 / 183 |
bladder | 95% | 1018.81 | 20 / 21 | 18% | 1.32 | 90 / 504 |
intestine | 65% | 484.28 | 627 / 966 | 44% | 2.68 | 232 / 527 |
adipose | 100% | 2598.59 | 1199 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2093.94 | 1316 / 1335 | 0% | 0 | 0 / 0 |
lung | 40% | 210.34 | 231 / 578 | 23% | 1.48 | 267 / 1155 |
muscle | 45% | 240.36 | 362 / 803 | 0% | 0 | 0 / 0 |
spleen | 45% | 351.26 | 108 / 241 | 0% | 0 | 0 / 0 |
heart | 37% | 199.02 | 321 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 24% | 1.67 | 19 / 80 |
tonsil | 0% | 0 | 0 / 0 | 20% | 1.28 | 9 / 45 |
brain | 3% | 15.31 | 88 / 2642 | 9% | 0.55 | 62 / 705 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.42 | 3 / 29 |
peripheral blood | 0% | 1.31 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0055062 | Biological process | phosphate ion homeostasis |
GO_0006091 | Biological process | generation of precursor metabolites and energy |
GO_0090304 | Biological process | nucleic acid metabolic process |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0030643 | Biological process | intracellular phosphate ion homeostasis |
GO_0033198 | Biological process | response to ATP |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0006796 | Biological process | phosphate-containing compound metabolic process |
GO_0030500 | Biological process | regulation of bone mineralization |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0046034 | Biological process | ATP metabolic process |
GO_0006955 | Biological process | immune response |
GO_0030730 | Biological process | sequestering of triglyceride |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_1990787 | Biological process | negative regulation of hh target transcription factor activity |
GO_0030318 | Biological process | melanocyte differentiation |
GO_0030505 | Biological process | inorganic diphosphate transport |
GO_0030502 | Biological process | negative regulation of bone mineralization |
GO_0030282 | Biological process | bone mineralization |
GO_0009143 | Biological process | nucleoside triphosphate catabolic process |
GO_0050427 | Biological process | 3'-phosphoadenosine 5'-phosphosulfate metabolic process |
GO_0010467 | Biological process | gene expression |
GO_0031953 | Biological process | negative regulation of protein autophosphorylation |
GO_0045719 | Biological process | negative regulation of glycogen biosynthetic process |
GO_0046325 | Biological process | negative regulation of glucose import |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005158 | Molecular function | insulin receptor binding |
GO_0004527 | Molecular function | exonuclease activity |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0030247 | Molecular function | polysaccharide binding |
GO_0036221 | Molecular function | UTP diphosphatase activity |
GO_0036219 | Molecular function | GTP diphosphatase activity |
GO_0106177 | Molecular function | cyclic-GMP-AMP hydrolase activity |
GO_0047693 | Molecular function | ATP diphosphatase activity |
GO_0005044 | Molecular function | scavenger receptor activity |
GO_0050656 | Molecular function | 3'-phosphoadenosine 5'-phosphosulfate binding |
GO_0004528 | Molecular function | phosphodiesterase I activity |
GO_0047429 | Molecular function | nucleoside triphosphate diphosphatase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004551 | Molecular function | dinucleotide phosphatase activity |
GO_0016791 | Molecular function | phosphatase activity |
GO_0004115 | Molecular function | 3',5'-cyclic-AMP phosphodiesterase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ENPP1 |
Protein name | Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)] Ectonucleotide pyrophosphatase/phosphodiesterase 1 |
Synonyms | M6S1 PC1 PDNP1 NPPS |
Description | FUNCTION: Nucleotide pyrophosphatase that generates diphosphate (PPi) and functions in bone mineralization and soft tissue calcification by regulating pyrophosphate levels (By similarity). PPi inhibits bone mineralization and soft tissue calcification by binding to nascent hydroxyapatite crystals, thereby preventing further growth of these crystals . Preferentially hydrolyzes ATP, but can also hydrolyze other nucleoside 5' triphosphates such as GTP, CTP and UTP to their corresponding monophosphates with release of pyrophosphate, as well as diadenosine polyphosphates, and also 3',5'-cAMP to AMP . May also be involved in the regulation of the availability of nucleotide sugars in the endoplasmic reticulum and Golgi, and the regulation of purinergic signaling . Inhibits ectopic joint calcification and maintains articular chondrocytes by repressing hedgehog signaling; it is however unclear whether hedgehog inhibition is direct or indirect (By similarity). Appears to modulate insulin sensitivity and function . Also involved in melanogenesis . Also able to hydrolyze 2',3'-cGAMP (cyclic GMP-AMP), a second messenger that activates TMEM173/STING and triggers type-I interferon production . 2',3'-cGAMP degradation takes place in the lumen or extracellular space, and not in the cytosol where it is produced; the role of 2',3'-cGAMP hydrolysis is therefore unclear . Not able to hydrolyze the 2',3'-cGAMP linkage isomer 3'-3'-cGAMP . . |
Accessions | A0A3B3IST7 ENST00000647893.1 ENST00000650147.1 A0A3B3ISN7 ENST00000650507.1 ENST00000650437.1 A0A3B3IU14 ENST00000513998.5 E9PE72 P22413 |